Development of a Novel Photosensitizer for Photodynamic Therapy of Cancer

Total Page:16

File Type:pdf, Size:1020Kb

Development of a Novel Photosensitizer for Photodynamic Therapy of Cancer Luís Gabriel Borges Rocha Development of a novel photosensitizer for Photodynamic Therapy of cancer Tese de doutoramento em Ciências Farmacêuticas, especialidade em Biotecnologia Farmacêutica, orientada pelo Professor Doutor Sérgio Simões e pelo Professor Doutor Luís G. Arnaut e apresentada à Faculdade de Farmácia da Universidade de Coimbra Outubro de 2015 Luís Gabriel Borges Rocha Development of a novel photosensitizer for Photodynamic Therapy of cancer 2015 FACULDADE DE FARMÁCIA DA UNIVERSIDADE DE COIMBRA Tese de doutoramento em Ciências Farmacêuticas, especialidade em Biotecnologia Farmacêutica, apresentada à Faculdade de Farmácia da Universidade de Coimbra Doctoral thesis in Pharmaceutical Sciences, specialty in Pharmaceutical Biotechnology, presented to the Faculty of Pharmacy of the University of Coimbra. Orientadores Científicos / Scientific Supervisors: Professor Doutor Sérgio Simões Faculdade de Farmácia da Universidade de Coimbra Professor Doutor Luís G. Arnaut Faculdade de Ciências e Tecnologia da Universidade de Coimbra The studies presented in this thesis were performed at Bluepharma – Indústria Farmacêutica, SA, Chemistry Department of the Faculty of Sciences and Technology of the University of Coimbra, Centre for Neuroscience and Cell Biology of the University of Coimbra and Instituto Nacional de Investigação Agrária e Veterinária in Santarém, Portugal. The work was funded by Bluepharma – Indústria Farmacêutica, SA and Luzitin, SA, which received additional financial support from the National Strategic Reference Framework’s Programme (QREN) nº 5356, from November 2010 until October 2013. Para a Sónia, Beatriz e Rodrigo, as estrelas mais brilhantes no meu Universo! Science is the only light in the dark paths of the unknown. Let there be light Genesis 1:3 Table of Contents Agradecimentos -----------------------------------------------------------------------------------------------iii Thesis Abstract -------------------------------------------------------------------------------------------------v Resumo da Tese ----------------------------------------------------------------------------------------------vii List of Abbreviations ------------------------------------------------------------------------------------------xi List of Figures -- ------------------------------------------------------------------------------------------------xv List of Tables --------------------------------------------------------------------------------------------------xvii Chapter 1 – General Introduction ------------------------------------------------------------------------------------ 3 1.1. Preamble ---------------------------------------------------------------------------------------------------------- 4 1.2. Challenges in cancer therapy – Photodynamic Therapy as an alternative for cancer treatment --------------------------------------------------------------------------------------------------------------- 5 1.3. History of Photodynamic Therapy --------------------------------------------------------------------------- 6 1.4. Mechanism of action ------------------------------------------------------------------------------------------- 7 1.5. Photodynamic Therapy in clinical practice -------------------------------------------------------------- 10 1.6. Advantages and limitations --------------------------------------------------------------------------------- 11 1.7. Light, photosensitizers and oxygen ----------------------------------------------------------------------- 13 1.7.1. Light --------------------------------------------------------------------------------------------------------- 13 1.7.2. Photosensitizers ------------------------------------------------------------------------------------------ 15 1.7.3. Oxygen------------------------------------------------------------------------------------------------------ 17 1.8. Photosensitizer biodistribution and intracellular localization -------------------------------------- 20 1.8.1. Topical application -------------------------------------------------------------------------------------- 20 1.8.2. Systemic administration ------------------------------------------------------------------------------- 21 1.8.3. Intracellular localization -------------------------------------------------------------------------------- 22 1.9. Mechanisms of cell death ----------------------------------------------------------------------------------- 23 1.9.1. Autophagy ------------------------------------------------------------------------------------------------- 23 1.9.2. Apoptosis -------------------------------------------------------------------------------------------------- 24 1.9.3. Necrosis ---------------------------------------------------------------------------------------------------- 24 1.10. Mechanisms of resistance --------------------------------------------------------------------------------- 25 1.11. PDT dosimetry ------------------------------------------------------------------------------------------------ 26 1.12. Photodynamic threshold dose and effective treatment depth ----------------------------------- 27 1.13. Modes of action of Photodynamic Therapy ----------------------------------------------------------- 28 1.13.1. Effects on tumour cells ------------------------------------------------------------------------------- 28 1.13.2. Effects on blood vessels ------------------------------------------------------------------------------ 29 1.13.3. Effects on the immune system ---------------------------------------------------------------------- 30 i 1.14. Recent developments --------------------------------------------------------------------------------------- 33 1.15. Development of redaporfin for PDT of cancer -------------------------------------------------------- 35 1.15.1. Project context ------------------------------------------------------------------------------------------ 37 1.16. Objectives ------------------------------------------------------------------------------------------------------ 39 Chapter 2 – In vitro Biological Activity ----------------------------------------------------------------------------- 43 2.1. Abstract ---------------------------------------------------------------------------------------------------------- 44 2.2. Introduction ----------------------------------------------------------------------------------------------------- 44 2.3. Material and methods ---------------------------------------------------------------------------------------- 45 2.4. Results and discussion ---------------------------------------------------------------------------------------- 49 2.5. Conclusion ------------------------------------------------------------------------------------------------------- 53 Chapter 3 – Pharmaceutical Development and Proof-of-Concept ----------------------------------------- 57 3.1. Abstract ---------------------------------------------------------------------------------------------------------- 58 3.2. Introduction ----------------------------------------------------------------------------------------------------- 58 3.3. Materials and methods --------------------------------------------------------------------------------------- 60 3.4. Results and discussion ---------------------------------------------------------------------------------------- 64 3.5. Conclusion ------------------------------------------------------------------------------------------------------- 73 Chapter 4 – Nonclinical Safety Evaluation ------------------------------------------------------------------------ 79 4.1. Abstract ---------------------------------------------------------------------------------------------------------- 80 4.2. Introduction ----------------------------------------------------------------------------------------------------- 80 4.3. Materials and methods --------------------------------------------------------------------------------------- 81 4.4. Results and discussion ---------------------------------------------------------------------------------------- 86 4.5. Conclusion ------------------------------------------------------------------------------------------------------- 91 Chapter 5 – Towards a clinical protocol --------------------------------------------------------------------------- 95 5.1. Abstract ---------------------------------------------------------------------------------------------------------- 96 5.2. Introduction ----------------------------------------------------------------------------------------------------- 96 5.3. Materials and methods --------------------------------------------------------------------------------------- 97 5.4. Results ---------------------------------------------------------------------------------------------------------- 101 5.5. Discussion------------------------------------------------------------------------------------------------------ 105 5.6. Conclusion ----------------------------------------------------------------------------------------------------- 108 Chapter 6 – General Conclusion and Future Perspectives -------------------------------------------------- 111 7.1. References ----------------------------------------------------------------------------------------------------- 115 ii Agradecimentos Pessoalmente, este trabalho representa o ponto mais alto de uma fascinante viagem que teve início no já longínquo ano de 2006. A todos os que durante este trajeto contribuíram de forma construtiva para o resultado final, quero manifestar
Recommended publications
  • Singlet Oxygen Production by Peptide-Coated Quantum Dot-Photosensitizer Conjugates James M
    Published on Web 05/04/2007 Singlet Oxygen Production by Peptide-Coated Quantum Dot-Photosensitizer Conjugates James M. Tsay,†,|,§ Michael Trzoss,† Lixin Shi,⊥ Xiangxu Kong,†,| Matthias Selke,⊥ Michael E. Jung,† and Shimon Weiss*,†,‡,| Contribution from the Department of Chemistry and Biochemistry, Department of Physiology, and California NanoSystems Institute, UniVersity of California at Los Angeles, Los Angeles, California 90095, and Department of Chemistry, California State UniVersity, Los Angeles, Los Angeles, California 90032 Received January 31, 2007; E-mail: [email protected] Abstract: Peptide-coated quantum dot-photosensitizer conjugates were developed using novel covalent conjugation strategies on peptides which overcoat quantum dots (QDs). Rose bengal and chlorin e6, photosensitizers (PSs) that generate singlet oxygen in high yield, were covalently attached to phytochelatin- related peptides. The photosensitizer-peptide conjugates were subsequently used to overcoat green- and red-emitting CdSe/CdS/ZnS nanocrystals. Generation of singlet oxygen could be achieved via indirect excitation through Fo¨rster (fluorescence) resonance energy transfer (FRET) from the nanocrystals to PSs, or by direct excitation of the PSs. In the latter case, by using two color excitations, the conjugate could be simultaneously used for fluorescence imaging and singlet oxygen generation. Singlet oxygen quantum yields as high as 0.31 were achieved using 532-nm excitation wavelengths. 1. Introduction cancer, (3) have efficient energy transfer to O2, (4) be easily cleared from the body, (5) be resistant to aggregation, and (6) Photodynamic therapy (PDT) has emerged as a highly be photostable.1,3 Unfortunately, even the most successful PSs, 1,2 effective treatment for oncological diseases. It relies on the such as Photofrin, have major drawbacks: poor water solubility, effective localization of photosensitizers (PSs) into tumor tissues low selectivity, skin phototoxicity, and instability.
    [Show full text]
  • Photosensitizer-Functionalized Nanocomposites for Light-Activated Cancer Theranostics
    International Journal of Molecular Sciences Review Photosensitizer-Functionalized Nanocomposites for Light-Activated Cancer Theranostics Banendu Sunder Dash 1 , Suprava Das 1 and Jyh-Ping Chen 1,2,3,4,* 1 Department of Chemical and Materials Engineering, Chang Gung University, Kwei-San, Taoyuan 33302, Taiwan; [email protected] (B.S.D.); [email protected] (S.D.) 2 Craniofacial Research Center, Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Linkou, Kwei-San, Taoyuan 33305, Taiwan 3 Research Center for Food and Cosmetic Safety, Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan 33305, Taiwan 4 Department of Materials Engineering, Ming Chi University of Technology, Tai-Shan, New Taipei City 24301, Taiwan * Correspondence: [email protected]; Tel.: +886-3-2118800 Abstract: Photosensitizers (PSs) have received significant attention recently in cancer treatment due to its theranostic capability for imaging and phototherapy. These PSs are highly responsive to light source of a suitable wavelength for image-guided cancer therapy from generated singlet oxygen and/or thermal heat. Various organic dye PSs show tremendous attenuation of tumor cells during cancer treatment. Among them, porphyrin and chlorophyll-based ultraviolet-visible (UV-Vis) dyes are employed for photodynamic therapy (PDT) by reactive oxygen species (ROS) and free radicals generated with 400–700 nm laser lights, which have poor tissue penetration depth. To enhance the efficacy of PDT, other light sources such as red light laser and X-ray have been suggested; nonetheless, it is still a challenging task to improve the light penetration depth for deep tumor treatment.
    [Show full text]
  • Chlorophyll Biosynthesis
    Chlorophyll Biosynthesis: Various Chlorophyllides as Exogenous Substrates for Chlorophyll Synthetase Jürgen Benz and Wolfhart Rüdiger Botanisches Institut, Universität München, Menziger Str. 67, D-8000 München 19 Z. Naturforsch. 36 c, 51 -5 7 (1981); received October 10, 1980 Dedicated to Professor Dr. H. Merxmüller on the Occasion of His 60th Birthday Chlorophyllides a and b, Protochlorophyllide, Bacteriochlorophyllide a, 3-Acetyl-3-devinylchlo- rophyllide a, Pyrochlorophyllide a, Pheophorbide a The esterification of various chlorophyllides with geranylgeranyl diphosphate was investigated as catalyzed by the enzyme chlorophyll synthetase. The enzyme source was an etioplast membrane fraction from etiolated oat seedlings ( Avena sativa L.). The following chlorophyllides were prepared from the corresponding chlorophylls by the chlorophyllase reaction: chlorophyllide a (2) and b (4), bacteriochlorophyllide a (5), 3-acetyl-3-devinylchlorophyllide a (6), and pyro­ chlorophyllide a (7). The substrates were solubilized with cholate which reproducibly reduced the activity of chlorophyll synthetase by 40-50%. It was found that the following compounds were good substrates for chlorophyll synthetase: chlorophyllide a and b, 3-acetyl-3-devinylchloro- phyllide a, and pyrochlorophyllide a. Only a poor or no reaction was found with protochloro­ phyllide, pheophorbide a, and bacteriochlorophyllide. This difference of reactivity was not due to distribution differences of the substrates between solution and pelletable membrane fraction. Furthermore, no interference between good and poor substrate was detected. Structural features necessary for chlorophyll synthetase substrates were discussed. Introduction Therefore no exogenous 2 was applied. The only substrate was 2 formed by photoconversion of endo­ The last steps of chlorophyll a (Chi a) biosynthe­ genous Protochlide (1) in the etioplast membrane.
    [Show full text]
  • Detergent-Induced Self-Assembly and Controllable Photosensitizer Activity of Diester Phenylene Ethynylenes
    Detergent-induced self-assembly and controllable photosensitizer activity of diester phenylene ethynylenes Patrick L. Donabediana,b, Matthew N. Creyerc, Florencia A. Mongeb,d, Kirk S. Schanzee,1, Eva Y. Chib,f, and David G. Whittenb,f,2 aNanoscience and Microsystems Engineering Graduate Program, University of New Mexico, Albuquerque, NM 87131; bCenter for Biomedical Engineering, University of New Mexico, Albuquerque, NM 87131; cDepartment of Chemistry, University of Wisconsin–Madison, Madison, WI 53706; dBiomedical Engineering Graduate Program, University of New Mexico, Albuquerque, NM 87131; eDepartment of Chemistry, University of Florida, Gainesville, FL 32611; and fDepartment of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM 87131 Edited by Vivian Wing-Wah Yam, The University of Hong Kong, Hong Kong, China, and approved May 25, 2017 (received for review February 14, 2017) Photodynamic therapy, in which malignant tissue is killed by investigations of switchable photosensitizers by various groups targeted light exposure following administration of a photosen- have used a pH-activatable rubyrin derivative (13), a quencher- sitizer, can be a valuable treatment modality but currently relies tethered Si(IV) phthalocyanine (14) and pyropheophorbide (15), on passive transport and local irradiation to avoid off-target and various boron-dipyrromethene (BODIPY) dye-based scaf- oxidation. We present a system of excited-state control for truly folds (16–18). Solvent microenvironment has been used to se- local delivery of singlet oxygen. An anionic phenylene ethynylene lectively photooxidize protein (19) and cellular targets (17), but oligomer is initially quenched by water, producing minimal only using intramolecular FRET quenching or solvent polarity fluorescence and no measurable singlet oxygen generation.
    [Show full text]
  • Antibacterial Photosensitization Through Activation of PNAS PLUS Coproporphyrinogen Oxidase
    Antibacterial photosensitization through activation of PNAS PLUS coproporphyrinogen oxidase Matthew C. Surdela, Dennis J. Horvath Jr.a, Lisa J. Lojeka, Audra R. Fullena, Jocelyn Simpsona, Brendan F. Dutterb,c, Kenneth J. Sallenga, Jeremy B. Fordd, J. Logan Jenkinsd, Raju Nagarajane, Pedro L. Teixeiraf, Matthew Albertollec,g, Ivelin S. Georgieva,e,h, E. Duco Jansend, Gary A. Sulikowskib,c, D. Borden Lacya,d, Harry A. Daileyi,j,k, and Eric P. Skaara,1 aDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232; bDepartment of Chemistry, Vanderbilt University, Nashville, TN 37232; cVanderbilt Institute for Chemical Biology, Nashville, TN 37232; dDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232; eVanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232; fBiomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN 37203; gDepartment of Biochemistry, Vanderbilt University, Nashville, TN 37232; hDepartment of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN 37232; iBiomedical and Health Sciences Institute, University of Georgia, Athens, GA 30602; jDepartment of Microbiology, University of Georgia, Athens, GA 30602; and kDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602 Edited by Ferric C. Fang, University of Washington School of Medicine, Seattle, WA, and accepted by Editorial Board Member Carl F. Nathan June 26, 2017 (received for review January 10, 2017) Gram-positive bacteria cause the majority of skin and soft tissue Small-molecule VU0038882 (‘882) was previously identified in infections (SSTIs), resulting in the most common reason for clinic a screen for activators of the S. aureus heme-sensing system two- visits in the United States.
    [Show full text]
  • Organic–Inorganic Hybrid Nanosystems for Photodynamic Therapy
    PhysBioSymp17 The 2nd International Symposium on KnE Energy & Physics Physics, Engineering and Technologies for Biomedicine Volume 2018 Conference Paper Organic–Inorganic Hybrid Nanosystems for Photodynamic Therapy Rakovich Yu.P.1,2 1Materials Physics Center, University of the Basque Country, IKERBASQUE, Donostia-San Sebastián, Spain 2National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe shosse 31, Moscow, 115409, Russia Abstract The purpose of this study is to investigate the possibility of improving the efficiency of a photosensitizer utilizing colloidal semiconductor quantum dots as light-harvesting nanoantenna and reveal the mechanism of this enhancement. Keywords: quantum dots, photosensitizer, photodynamic therapy, FRET, charge transfer Corresponding Author: Rakovich Yu.P. [email protected] Received: 17 January 2018 1. Introduction Accepted: 25 March 2018 Published: 17 April 2018 Photodynamic (PD) therapy takes advantages of light absorption by light-sensitive Publishing services provided by photosensitizers and the generation of photochemical species such as singlet oxy- Knowledge E 1 gen ( O2) or other reactive oxygen species (ROS) linked to apoptosis or necrosis Rakovich Yu.P.. This article is of cancerous cells.[1] One of the necessary conditions for the efficient generation distributed under the terms of the Creative Commons of ROS is wavelength matching of excitation wavelength to optical absorption of a Attribution License, which photosensitizer.[2] permits unrestricted use and redistribution provided that the Upon last decades, there have been a lot of research activities directed toward original author and source are the development of PD complexes based on different nanomaterials which are able credited. to expand the excitation spectral region beyond the absorption of a photosensitizer Selection and Peer-review and to enhance the efficiency of ROS generation.[3] Among others, semiconductor under the responsibility of the quantum dots (QDs) are highly attractive for PD therapy applications.
    [Show full text]
  • Phyllobilins – the Abundant Bilin-Type Tetrapyrrolic Catabolites Of
    Chemical Society Reviews Phyllobilins – the Abundant Bilin -Type Tetrapyrrolic Catabolites of the Green Plant Pigment Chlorophyll Journal: Chemical Society Reviews Manuscript ID: CS-TRV-02-2014-000079.R1 Article Type: Tutorial Review Date Submitted by the Author: 02-May-2014 Complete List of Authors: Krautler, Bernhard; University of Innsbruck, Institute of Organic Chemistry Page 1 of 30 Chemical Society Reviews Phyllobilins-TutRev-BKräutler 2-May-14 1 Phyllobilins – the Abundant Bilin-type Tetrapyrrolic Catabolites of the Green Plant Pigment Chlorophyll Bernhard Kräutler Institute of Organic Chemistry and Centre of Molecular Biosciences, University of Innsbruck, Innrain 80/82, A-6020 Innsbruck, Austria E-mail: [email protected] Abstract . The seasonal disappearance of the green plant pigment chlorophyll in the leaves of deciduous trees has long been a fascinating biological puzzle. In the course of the last two and a half decades, important aspects of the previously enigmatic breakdown of chlorophyll in higher plants were elucidated. Crucial advances in this field were achieved by the discovery and structure elucidation of tetrapyrrolic chlorophyll catabolites, as well as by complementary biochemical and plant biological studies. Phyllobilins, tetrapyrrolic, bilin-type chlorophyll degradation products, are abundant chlorophyll catabolites, which occur in fall leaves and in ripe fruit. This tutorial review outlines ‘how’ chlorophyll is degraded in higher plants, and gives suggestions as to ‘why’ the plants dispose of their valuable green pigments during senescence and ripening. Insights into chlorophyll breakdown help satisfy basic human curiosity and enlighten school teaching. They contribute to fundamental questions in plant biology and may have practical consequences in agriculture and horticulture.
    [Show full text]
  • Synthesis of Photocleavable Photosensitizer-Drug
    SYNTHESIS OF PHOTOCLEAVABLE PHOTOSENSITIZER-DRUG COMPLEXES by MICHAEL YANGBO JIANG B. Sc. Xiamen University, 1998 A THESIS SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE STUDIES (Chemistry) THE UNIVERSITY OF BRITISH COLUMBIA May 2007 © Michael Yangbo Jiang, 2007 Abstract The objective of this work was to develop a "photodyNamic" site-specific drug delivery methodology, whereby a drug can be released by visible light at the site of irradiation. This goal was fulfilled by connecting the target drug molecule with a photosensitizer through a specially-designed double-bond linkage. Upon visible light illumination, the photosensitizer moiety of the final complex converted ground-state oxygen to the high energized singlet oxygen, which can oxidatively cleave the olefin linkage to release the drug via a tandem [2+2] cyvloaddition-dioxetane decomposition process. Our first synthetic strategy was to combine bioactive carboxylic acids with alkynylporphyrins using a ruthenium-catalyzed addition reaction. However, the preparation of the alkynylporphyrin substrate was unsuccessful. An alternative synthesis was proposed by adding the carboxylic acid to ethoxyacetylene first, but the subsequent Heck coupling of the resulting alkene to porphyrins failed as well. However, an interesting reaction intermediate 11-21-Zn was isolated and characterized by X-ray crystallography. Its formation mechanism and catalytic activity were also studied. Second Generation Linker The first generation complexes were successfully synthesized using the linker molecule 111-15. Esters as drug mimics were first attached to the linker to form an enol ether linkage by Takai alkylidenation and photosensitizers were then attached by esterification.
    [Show full text]
  • Utilization of Naturally Occurring Dyes As Sensitizers in Dye Sensitized Solar Cells
    Utilization of Naturally Occurring Dyes as Sensitizers in Dye Sensitized Solar Cells. Nipun Sawhney 1, Soumitra Satapathi 1,* 1 Department of Physics, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, 247667, India Abstract Dye sensitized Solar cells (DSSCs) were fabricated with four naturally occurring anthocyanin dyes extracted from naturally found fruits/ juices (viz. Indian Jamun, Plum, Black Currant and Berries) as sensitizers. Extraction of anthocyanin was done using acidified ethanol. The highest power conversion efficiencies (η) of 0.55% and 0.53% were achieved for the DSSCs fabricated using anthocyanin extracts of blackcurrant and mixed berry juice. Widespread availability of these fruits/juices, high concentration of anthocyanins in them and ease of extraction of anthocyanin dyes from these commonly available fruits render them novel and inexpensive candidates for solar cell fabrication. Keywords Dye Sensitized Solar Cells (DSSC); Sensitizer; Natural Dyes; Anthocyanin Extraction * Corresponding Author: [email protected] 1 1. Introduction Dye sensitized solar cells (DSSCs) or Gratzel cells as discovered by Gratzel et.al.in 1991 have attracted considerable research interest due to their low cost, ease of fabrication and environmental friendliness [1,2]. A DSSC is composed of a porous layer of titanium dioxide (TiO2) coated photoanode, a monolayer of dye molecules that absorbs sunlight, an electrolyte for dye regeneration and a cathode. They form a sandwich like structure with the dye molecule or photosensitizer playing a pivotal role through its ability to absorb visible light photons. Therefore, a significant amount of research on DSSC has been focused on designing and optimizing the photosensitizer in order to absorb a wide spectrum of wavelengths and increase the efficiency of the solar energy conversion [3,4].
    [Show full text]
  • Investigation of Green Dye-Sensitized Solar Cells Based on Natural Dyes M
    World Academy of Science, Engineering and Technology International Journal of Chemical and Molecular Engineering Vol:11, No:6, 2017 Investigation of Green Dye-Sensitized Solar Cells Based on Natural Dyes M. Hosseinnezhad, K. Gharanjig efficiency of 0.12%-0.37% [7]. Wongcharee et al. assembled Abstract—Natural dyes, extracted from black carrot and bramble, DSSCs based on rosella, blue pea and mixed extracts. The were utilized as photosensitizers to prepare dye-sensitized solar cells highest power conversion efficiency of 0.37% has been (DSSCs). Spectrophotometric studies of the natural dyes in solution obtained for rosella extract. The results show that the and on a titanium dioxide substrate were carried out in order to assess temperature of extraction processing decreased the changes in the status of the dyes. The results show that the bathochromic shift is seen on the photo-electrode substrate. The performance of devices [8]. Fernando et al. fabricated DSSCs chemical binding of the natural dyes at the surface photo-electrode cells based on natural dyes extracted from tropical flowers. were increased by the chelating effect of the Ti(IV) ions. The cyclic The highest power conversion efficiency of 1.14% has been voltammetry results showed that all extracts are suitable to be obtained for hibiscus flowers [9]. Bathi et al. studied the performed in DSSCs. Finally, photochemical performance and performance of DSSCs based on Lawsonia inermis leaves, stability of DSSCs based on natural dyes were studied. The DSSCs sumac/rhus fruits and Curcuma longa roots. The highest sensitized by black carrot extract have been reported to achieve up to Jsc=1.17 mAcm-2, Voc= 0.55 V, FF= 0.52, η=0.34%, whereas power conversion efficiency of 1.5% has been obtained for red Bramble extract can obtain up to Jsc=2.24 mAcm-2, Voc= 0.54 V, purple sumac [10].
    [Show full text]
  • Enhancing the Performance of Dye Sensitized Solar Cells Using Silver Nanoparticles Modified Photoanode
    molecules Article Enhancing the Performance of Dye Sensitized Solar Cells Using Silver Nanoparticles Modified Photoanode Faizah Saadmim 1, Taseen Forhad 1, Ahmed Sikder 1, William Ghann 1 , Meser M. Ali 2, Viji Sitther 3 , A. J. Saleh Ahammad 4 , Md. Abdus Subhan 5 and Jamal Uddin 1,* 1 Center for Nanotechnology, Department of Natural Sciences, Coppin State University, 2500 W. North Ave, Baltimore, MD 21216, USA; [email protected] (F.S.); [email protected] (T.F.); [email protected] (A.S.); [email protected] (W.G.) 2 Department of Neurosurgery, Cellular and Molecular Imaging Laboratory, Henry Ford Hospital, Detroit, MI 48202, USA; [email protected] 3 School of Computer, Morgan State University, Mathematical and Natural Sciences, Morgan State University, Baltimore, MD 21251, USA; [email protected] 4 Department of Chemistry, Jagannath University, Dhaka 1100, Bangladesh; [email protected] 5 Department of Chemistry, School of Physical Sciences, Shah Jalal University of Science and Technology, Sylhet 3114, Bangladesh; [email protected] * Correspondence: [email protected] Academic Editor: Mário Calvete Received: 22 July 2020; Accepted: 1 September 2020; Published: 3 September 2020 Abstract: In this study, silver nanoparticles were synthesized, characterized, and applied to a dye-sensitized solar cell (DSSC) to enhance the efficiency of solar cells. The synthesized silver nanoparticles were characterized with UV–Vis spectroscopy, dynamic light scattering, transmission electron microscopy, and field emission scanning electron microscopy. The silver nanoparticles infused titanium dioxide film was also characterized by Fourier transform infrared and Raman spectroscopy. The performance of DSSC fabricated with silver nanoparticle-modified photoanode was compared with that of a control group.
    [Show full text]
  • Quantum Dots in Photodynamic Therapy for Cancer
    Journal of Analytical & Pharmaceutical Research Quantum Dots in Photodynamic Therapy for Cancer Abstract Opinion Photodynamic therapy (PDT) is a promising, non-invasive therapeutic approach. Volume 3 Issue 2 - 2016 PDT involves Photosensitizer (PS) drugs and an external light source is the essential components of PDT and cytotoxic reactive oxygen species are generated that destroys cancer cells. Despite of a new potential anticancer therapeutic strategy, success of PDT is limited due to low water solubility of photosensitizers National Chemical Laboratory, Organic Chemistry Division, India which limits the wide applicability of these molecules. Nano-platforms based on PS incorporated in nanomaterials can be applied for targeted PDT with reduced *Corresponding author: Preeti Nigam Joshi, National side effects and better efficiency. This article provides an insight on few recent Chemical Laboratory, Organic Chemistry Division, Pune- advancements of quantum dots based PDT and future aspects. 411008, India, Tel: +91-20-2590-2443; E-mail: Keywords: Photodynamic therapy; Nanotechnology; Quantum dots; Cancer; Photosensitizers; Nano-platforms Received: September 27, 2016 | Published: October 07, 2016 Abbreviations: PDT: Photodynamic Therapy; PS: procedures with relatively short span of side effects as compare to Photosensitizer; NIR: Near Infra Red; ALA: Aminolevulinic chemotherapy or radiotherapy. Based on its mode of action, it also Acid; MAOP: Methyl Aminolevulinate; BRET: Bioluminescence annihilates the vasculature associated with the tumor
    [Show full text]